Switch to: References

Add citations

You must login to add citations.
  1. Benefit Sharing – From Biodiversity to Human Genetics.Doris Schroeder & Julie Cook Lucas (eds.) - 2013 - Dordrecht, Netherlands: Springer.
    Biomedical research is increasingly carried out in low- and middle-income countries. International consensus has largely been achieved around the importance of valid consent and protecting research participants from harm. But what are the responsibilities of researchers and funders to share the benefits of their research with research participants and their communities? After setting out the legal, ethical and conceptual frameworks for benefit sharing, this collection analyses seven historical cases to identify the ethical and policy challenges that arise in relation to (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical Issues Surrounding Intellectual Property Rights.Jorn Sonderholm - 2010 - Philosophy Compass 5 (12):1107-1115.
    Much of today’s international trade is conducted according to trade agreements that involve substantial and uniform protections of intellectual property rights. Intellectual property rights are a socio‐economic tool that create a temporary monopoly for inventor firms and enable such firms to charge prices for their innovations that are many times higher than the marginal cost of production of the innovations. This allows the inventor firms to salvage their research‐costs and secure a profit on their innovations. A large body of contemporary (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • A moderate pluralist approach to public health policy and ethics.Michael J. Selgelid - 2009 - Public Health Ethics 2 (2):195-205.
    Centre for Applied Philosophy and Public Ethics, The Australian National University, LPO Box 8260, ANU, Canberra ACT 2601, Australia. Email: michael.selgelid{at}anu.edu.au ' + u + '@ ' + d + ' '/ /- ->. Home page: http: //www.cappe.edu.au/staff/michael-selgelid.htmThis article advocates the development of a moderate pluralist theory of political philosophy that recognizes that utility, liberty and equality are legitimate, independent social values and that none should have absolute priority over the others. Inter alia, such a theory would provide a principled (...)
    Download  
     
    Export citation  
     
    Bookmark   19 citations  
  • Incentivizing access and innovation for essential medicines: A survey of the problem and proposed solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
    Michael Ravvin, Department of Political Science, Columbia University, 420 W. 118th Street, New York, NY 10027 Email: mer2133{at}columbia.edu ' + u + '@' + d + ' '//--> Abstract The existing intellectual property regime discourages the innovation of, and access to, essential medicines for the poor in developing countries. A successful proposal to reform the existing system must address these challenges of access and innovation. This essay will survey the problems in the existing pharmaceutical patent system and offer critical analysis (...)
    Download  
     
    Export citation  
     
    Bookmark   11 citations  
  • A theoretical flaw in the advance market commitment idea.J. Sonderholm - 2010 - Journal of Medical Ethics 36 (6):339-343.
    Infectious and parasitic diseases cause massive health problems in the developing world. Research and development of drugs for diseases that mainly affect poor people in developing countries is limited. The advance market commitment (AMC) idea is an incentivising mechanism for research and development of drugs for neglected diseases. Discussion of the AMC idea is of renewed interest given the launch in June 2009 of the first AMC. This pilot AMC is designed to, among other things, test the idea for potential (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • A Reform Proposal in Need of Reform: A Critique of Thomas Pogge's Proposal for How to Incentivize Research and Development of Essential Drugs.J. Sonderholm - 2010 - Public Health Ethics 3 (2):167-177.
    In two recent essays, Thomas Pogge addresses the question of how research and development of essential drugs should be incentivized. Essential drugs are drugs for diseases that ruin human lives. The current incentivizing scheme for such drugs is, according to Pogge, a significant causal factor in bringing about a state of affairs in which millions of people die or suffer from lack of access to essential drugs. Pogge, therefore, suggests a reform plan for how to incentivize research and development of (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • The health impact fund: A useful supplement to the patent system?Aidan Hollis - 2008 - Public Health Ethics 1 (2):124-133.
    Department of Economics, University of Calgary, 2500 University Dr NW, Calgary AB, T2N 1N4, Canada. Tel.: +1403220 5861; Fax: +1403220 5861; Email: ahollis{at}ucalgary.ca ' + u + '@' + d + ' '//--> . Abstract The Health Impact Fund has been proposed as an optional, comprehensive advance market commitment system offering financial payments or ‘prizes’ to patentees of new drugs, which are sold globally at an administered low price. The Fund is designed to offer payments based on the therapeutic impact (...)
    Download  
     
    Export citation  
     
    Bookmark   18 citations